MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2016 International Congress

    Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration: Results of a large international multicenter study of 3206 patients (the QUALPD study)

    M. Skorvanek, P. Martinez-Martin, N. Kovacs, I. Zezula, M. Rodriguez-Violante, J.C. Corvol, P. Taba, K. Seppi, O. Levin, A. Schrag, T. Foltynie, M. Alvarez-Sanchez, T. Arakaki, Z. Aschermann, I. Aviles-Olmos, E. Benchetrit, C. Benoit, A. Bergareche-Yarza, A. Cervantes-Arriaga, A. Chade, F. Cormier, V. Datieva, D.A. Gallagher, N. Garretto, Z. Gdovinova, O. Gershanik, M. Grofik, V. Han, J. Huang, L. Kadastik-Eerme, M.M. Kurtis, G. Mangone, J.C. Martinez-Castrillo, A. Mendoza-Rodriguez, M. Minar, H.P. Moore, M. Muldmaa, C. Mueller, B. Pinter, W. Poewe, K. Rallmann, E. Reiter, C. Rodriguez-Blazquez, C. Singer, B.C. Tilley, P. Valkovic, C.G. Goetz, G.T. Stebbins (Kosice, Slovakia (Slovak Republic))

    Objective: To analyze the MDS-UPDRS part I-IV scores and their differences based on Hoehn and Yahr stage (HY) and disease duration in a large cohort…
  • 2016 International Congress

    Tremor amplitude detected by three-dimensional optical device provides good correlation to clinical rating scale

    K.H. Chen, P.C. Lin, Y.J. Chen, B.S. Yang, C.H. Lin, R.M. Wu (Hsin-Chu, Taiwan)

    Objective: To examine the feasibility of using a three-dimensional (3D) optical device served as tremor amplitude detection, we determined correlation between its results and clinical…
  • 2016 International Congress

    Gender and age-based differential item functioning (DIF) analysis of MDS-UPDRS

    C.G. Goetz, L. Wang, G.T. Stebbins, B.C. Tilley, S. Luo (Chicago, IL, USA)

    Objective: Test if DIF due to gender or age is present in MDS-UPDRS items. Background: Testing a rating scale for DIF is a core step…
  • 2016 International Congress

    Digitizing tablet and Fahn-Tolosa-Marín tremor ratings have comparable minimum detectable change

    R.J. Elble (Springfield, IL, USA)

    Objective: To determine if a digitizing tablet is better than Fahn-Tolosa-Marín part B (FTM-B) ratings in detecting changes in essential tremor (ET) that exceed random…
  • 2016 International Congress

    Patient reported outcomes in Parkinson’s disease (PRO-PD) rating scale validation

    L.K. Mischley (Kenmore, WA, USA)

    Objective: To evaluate whether a novel outcome measure, Patient-Reported Outcomes in Parkinson's disease (PRO-PD), correlates with disease duration, quality of life and established measures of…
  • 2016 International Congress

    A new tool to measure the impact of deep brain stimulation on Parkinson’s disease patients: Development and validation of the deep brain stimulation impairment scale (DBS-IS)

    F. Maier, C.J. Lewis, A.A. Kühn, H. Krug, J. Volkmann, A.D. Kirsch, L. Wojtecki, A. Schnitzler, G. Deuschl, J.K. Krauss, C. Woopen, L. Timmermann (Cologne, Germany)

    Objective: To develop a questionnaire that measures impairments related to deep brain stimulation (DBS). Background: DBS has considerable influence on motor and non-motor symptoms in…
  • 2016 International Congress

    Comparing tremor- and non-tremor effects of ethanol in patients with essential tremor

    J. Thompson-Westra, G. McCrossin, B. Voller, S. Auh, C. Lungu, S. Tinaz, V. Ramchandani, M. Hallett, D. Haubenberger (Bethesda, MD, USA)

    Objective: To explore the relationship between self-reported non-tremor effects of ethanol and objective tremor severity in Essential Tremor (ET). Background: Ethanol has been demonstrated to…
  • 2016 International Congress

    Empowering Parkinson’s patients to declare pain: A multicenter report of the use of the first Parkinson’s pain questionaire (King’s PD pain quest)

    A.M. Rizos, P. Martinez-Martin, S. Pal, R. Sophia, C. Carroll, D. Martino, C. Falup-Pecurariu, B. Kessel, T. Andrews, D. Paviour, A. Sauerbier, A. Martin, M. Parry, L. Perkins, D. Trivedi, T. Chiwera, P. Odin, A. Antonini, K. Ray Chaudhuri, On behalf of EUROPAR, The IPMDS Non-Motor PD Study Group (London, United Kingdom)

    Objective: To report the use of the first and easy to use self-completed Parkinson's specific pain questionnaire (King's PD Pain Quest (KPPQ), which is complementary…
  • 2016 International Congress

    The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years

    M. Matsushima, I. Yabe, I. Takahashi, K. Sakushima, F. Nakano, M. Hirotani, T. Kano, K. Horiuchi, H. Houzen, H. Sasaki (Sapporo, Japan)

    Objective: To examine the extent of disease progression for multiple system atrophy (MSA) during relatively long duration. Background: The knowledge of MSA natural history is…
  • 2016 International Congress

    The scale for assessment and rating of ataxia in early onset ataxia; always a reliable biomarker?

    R. Brandsma, T.F. Lawerman, M.J. Kuiper, I.J. Lunsing, H. Burger, D.A. Sival (Groningen, Netherlands)

    Objective: To determine the reliability and discriminant validity of the Scale for Assessment and Rating of Ataxia (SARA) in early onset ataxia. Background: Early onset…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley